Navigating the Metaverse: A New Virtual Tool with Promising Real Benefits for Breast Cancer Patients.
Weronika Magdalena ŻydowiczJarosław SkokowskiLuigi MaranoKarol PolomPublished in: Journal of clinical medicine (2024)
BC, affecting both women and men, is a complex disease where early diagnosis plays a crucial role in successful treatment and enhances patient survival rates. The Metaverse, a virtual world, may offer new, personalized approaches to diagnosing and treating BC. Although Artificial Intelligence (AI) is still in its early stages, its rapid advancement indicates potential applications within the healthcare sector, including consolidating patient information in one accessible location. This could provide physicians with more comprehensive insights into disease details. Leveraging the Metaverse could facilitate clinical data analysis and improve the precision of diagnosis, potentially allowing for more tailored treatments for BC patients. However, while this article highlights the possible transformative impacts of virtual technologies on BC treatment, it is important to approach these developments with cautious optimism, recognizing the need for further research and validation to ensure enhanced patient care with greater accuracy and efficiency.
Keyphrases
- peritoneal dialysis
- end stage renal disease
- artificial intelligence
- data analysis
- healthcare
- machine learning
- big data
- deep learning
- case report
- primary care
- pregnant women
- risk assessment
- chronic kidney disease
- combination therapy
- middle aged
- insulin resistance
- ejection fraction
- skeletal muscle
- prognostic factors
- quantum dots
- sensitive detection
- free survival